Barrington Research reaffirmed their outperform rating on shares of VerifyMe (NASDAQ:VRME – Free Report) in a report released on Wednesday morning,Benzinga reports. The brokerage currently has a $1.50 price objective on the stock. Barrington Research also issued estimates for VerifyMe’s Q4 2024 earnings at $0.00 EPS, FY2024 earnings at ($0.15) EPS, Q1 2025 earnings at ($0.06) EPS, FY2025 earnings at ($0.17) EPS and FY2026 earnings at ($0.17) EPS.
VerifyMe Price Performance
Shares of NASDAQ VRME opened at $1.00 on Wednesday. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.74 and a quick ratio of 1.73. The company has a market cap of $10.50 million, a price-to-earnings ratio of -3.23 and a beta of 0.67. The stock’s 50-day moving average is $1.30 and its two-hundred day moving average is $1.38. VerifyMe has a 1-year low of $0.90 and a 1-year high of $2.45.
VerifyMe (NASDAQ:VRME – Get Free Report) last released its earnings results on Tuesday, August 13th. The company reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.03. VerifyMe had a negative net margin of 13.15% and a negative return on equity of 11.15%. The firm had revenue of $5.35 million for the quarter, compared to analyst estimates of $5.71 million. During the same period in the prior year, the firm earned ($0.11) earnings per share. Analysts forecast that VerifyMe will post -0.19 EPS for the current fiscal year.
VerifyMe Company Profile
VerifyMe, Inc, together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions.
Read More
- Five stocks we like better than VerifyMe
- Ride Out The Recession With These Dividend KingsĀ
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Top-Performing Non-Leveraged ETFs This Year
- How to Invest in Biotech Stocks
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for VerifyMe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VerifyMe and related companies with MarketBeat.com's FREE daily email newsletter.